Systemic lupus erythematosus: Quest for safer treatment
Tuesday, June 17, 2014 - 17:02
in Health & Medicine
The treatment of systemic lupus erythematosus has traditionally been based on glucocorticoids administered orally. Nevertheless, these drugs were known to cause serious side effects. In order to determine whether a safety threshold exists in corticoid dose, researchers have conducted a study that has produced enlightening results. On the basis of these results and previous studies, the treatment currently being recommended for patients in the hospital limits the administering of glucocorticoids and favours the use of anti-malarial drugs as background treatment.